We have to look for a VRTX presentation slide from the phase-1b trial that shows viral-load decline on the y-axis and time (0 to 14 days) on the x-axis. If we find it, all we have to do is eyeball the viral-load decline at 5 days for the cohort of interest, which is 750mg TID.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”